Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2002 1
2003 2
2004 1
2005 1
2006 2
2007 5
2008 1
2009 7
2010 5
2011 11
2012 10
2013 20
2014 16
2015 26
2016 41
2017 40
2018 57
2019 78
2020 96
2021 86
2022 141
2023 111
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

697 results

Results by year

Filters applied: . Clear all
Page 1
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway.
Guo E, Xiao R, Wu Y, Lu F, Liu C, Yang B, Li X, Fu Y, Wang Z, Li Y, Huang Y, Li F, Wu X, You L, Qin T, Lu Y, Huang X, Ma D, Mills GB, Sun C, Chen G. Guo E, et al. Among authors: wu x. J Exp Med. 2022 Jan 3;219(1):e20210789. doi: 10.1084/jem.20210789. Epub 2021 Nov 26. J Exp Med. 2022. PMID: 34825915 Free PMC article.
Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.
Bao H, Wang Z, Ma X, Guo W, Zhang X, Tang W, Chen X, Wang X, Chen Y, Mo S, Liang N, Ma Q, Wu S, Xu X, Chang S, Wei Y, Zhang X, Bao H, Liu R, Yang S, Jiang Y, Wu X, Li Y, Zhang L, Tan F, Xue Q, Liu F, Cai S, Gao S, Peng J, Zhou J, Shao Y. Bao H, et al. Among authors: wu x. Mol Cancer. 2022 Jun 11;21(1):129. doi: 10.1186/s12943-022-01594-w. Mol Cancer. 2022. PMID: 35690859 Free PMC article. Clinical Trial.
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes.
Liu SY, Bao H, Wang Q, Mao WM, Chen Y, Tong X, Xu ST, Wu L, Wei YC, Liu YY, Chen C, Cheng Y, Yin R, Yang F, Ren SX, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yan HH, Dong S, Zhang XC, Su J, Yang JJ, Yang XN, Zhou Q, Wu X, Shao Y, Zhong WZ, Wu YL. Liu SY, et al. Among authors: wu x. Nat Commun. 2021 Nov 8;12(1):6450. doi: 10.1038/s41467-021-26806-7. Nat Commun. 2021. PMID: 34750392 Free PMC article. Clinical Trial.
Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer.
Wang S, Li M, Zhang J, Xing P, Wu M, Meng F, Jiang F, Wang J, Bao H, Huang J, Ren B, Yu M, Qiu N, Li H, Yuan F, Zhang Z, Jia H, Lu X, Zhang S, Wang X, Xu Y, Xia W, Liu T, Xu W, Xu X, Sun M, Wu X, Shao Y, Wang Q, Dai J, Qiu M, Wang J, Zhang Q, Xu L, Shen H, Yin R. Wang S, et al. Among authors: wu x. J Hematol Oncol. 2022 Oct 1;15(1):137. doi: 10.1186/s13045-022-01355-8. J Hematol Oncol. 2022. PMID: 36183093 Free PMC article.
697 results